cysteamine has been researched along with Chronic Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Acham-Roschitz, B; Arbeiter, K; Billing, H; Büscher, A; Haffner, D; Hagenberg, M; Hohenfellner, K; Jagodzinski, C; Kanzelmeyer, N; Kemper, MJ; Kluck, R; Müller, S; Oh, J; Pavičić, L; Thumfart, J; Tönshoff, B; Weber, LT; Zivicnjak, M | 1 |
| Bahrami, NM; Barshop, BA; Duffield, JS; Eddy, AA; Gangoiti, JA; Lopez-Guisa, JM; Okamura, DM; Pasichnyk, K; Ren, S; Williams, JM; Yamaguchi, I | 1 |
| Strutz, F | 1 |
3 other study(ies) available for cysteamine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Body growth, upper arm fat area, and clinical parameters in children with nephropathic cystinosis compared with other pediatric chronic kidney disease entities.
Topics: Adipose Tissue; Adolescent; Arm; Child; Child, Preschool; Cysteamine; Cystinosis; Fanconi Syndrome; Female; Growth Hormone; Humans; Male; Prospective Studies; Renal Insufficiency, Chronic | 2022 |
Cysteamine modulates oxidative stress and blocks myofibroblast activity in CKD.
Topics: Actins; Animals; Antioxidants; Cell Differentiation; Cell Line; Cell Proliferation; Cysteamine; Disease Models, Animal; Extracellular Matrix Proteins; Fibrosis; GTP-Binding Proteins; Macrophages; Male; Mice; Mice, Inbred C57BL; Myofibroblasts; Oxidative Stress; Protein Glutamine gamma Glutamyltransferase 2; Rats; Renal Insufficiency, Chronic; RNA, Messenger; Transglutaminases; Ureteral Obstruction | 2014 |
Antifibrotic therapy: is an antioxidative regimen the answer?
Topics: Animals; Antioxidants; Cysteamine; Male; Myofibroblasts; Renal Insufficiency, Chronic | 2014 |